Functional characterization of the 19q12 amplicon in grade III breast cancers
Rachael Natrajan(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Bas Kreike(The Netherlands Cancer Institute), Britta Weigelt(Memorial Sloan Kettering Cancer Center), Hugo M. Horlings, Marc J. van de Vijver(The Netherlands Cancer Institute), Alan Mackay(Institute of Cancer Research), Mónica Arnedos, Daniel Wetterskog(CRUK Lung Cancer Centre of Excellence), Felipe C. Geyer(Institute of Cancer Research), Kai-Keen Shiu(Institute of Cancer Research), Anita Langerød(Oslo University Hospital), Maryou B. Lambros(Institute of Cancer Research), Fabien Reyal(Université Paris Sciences et Lettres), Paul M Wilkerson(University Hospitals Bristol NHS Foundation Trust), José Palacios(American University)
Cited by 95
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k